tiprankstipranks
Trending News
More News >
Artivion announces presentation of Nexus device trial results
PremiumThe FlyArtivion announces presentation of Nexus device trial results
5d ago
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7d ago
Artivion Inc. Reports Strong 2024 Earnings Amid Challenges
Premium
Company Announcements
Artivion Inc. Reports Strong 2024 Earnings Amid Challenges
2M ago
Artivion’s Resilient Growth Potential: Overcoming Cybersecurity Setbacks with Strong Fundamentals and New Developments
PremiumRatingsArtivion’s Resilient Growth Potential: Overcoming Cybersecurity Setbacks with Strong Fundamentals and New Developments
2M ago
Artivion Inc. Reports Strong 2024 Financial Results
Premium
Company Announcements
Artivion Inc. Reports Strong 2024 Financial Results
2M ago
Closing Bell Movers: Hims  & Hers down nearly 20% on earnings miss
Premium
The Fly
Closing Bell Movers: Hims & Hers down nearly 20% on earnings miss
2M ago
Artivion reports hackers stole files during cybersecurity incident
PremiumThe FlyArtivion reports hackers stole files during cybersecurity incident
5M ago
Artivion: FDA grants HDE for use of  AMDS Hybrid Prosthesis
Premium
The Fly
Artivion: FDA grants HDE for use of AMDS Hybrid Prosthesis
5M ago
Artivion price target raised to $35 from $32 at Lake Street
Premium
The Fly
Artivion price target raised to $35 from $32 at Lake Street
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100